The efficacy and safety of immune combination therapy in patients with driver gene-negative non-small cell lung cancer with liver metastasis: a systematic review and network meta-analysis

Abstract Objective This study aimed to systematically evaluate the efficacy and safety of combination therapies with immune checkpoint inhibitors (ICIs) in patients with driver gene-negative non-small cell lung cancer (NSCLC) and liver metastases. These patients typically have poor prognosis and lim...

Full description

Saved in:
Bibliographic Details
Main Authors: Weixing Zhao, Bo Li, Yujia Gu, Xiaoni Jin, Zirui Li, Wanjing Guo, Xinxin Lu, Jun Jiang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-14712-w
Tags: Add Tag
No Tags, Be the first to tag this record!